BioPharma Credit PLC (LON:BPCR)

Market Cap	790.79M +2.1%
Revenue (ttm)	117.21M +5.1%
Net Income	96.51M +6.3%
EPS	0.08 +14.0%
Shares Out	1.13B
PE Ratio	8.25
Forward PE	n/a
Dividend	0.07 (10.59%)
Ex-Dividend Date	Feb 19, 2026

Volume	971,025
Average Volume	1,365,242
Open	0.9540
Previous Close	0.9400
Day's Range	0.9320 - 0.9540
52-Week Range	0.8220 - 0.9798
Beta	0.17
RSI	55.26
Earnings Date	Mar 24, 2026

About BioPharma Credit

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

• Industry: Asset Management
• Sector: Financials
• Founded: 2016
• Country: United Kingdom
• Stock Exchange: London Stock Exchange
• Ticker Symbol: BPCR

Financial Performance

In 2025, BioPharma Credit's revenue was $157.75 million, an increase of 5.14% compared to the previous year's $150.03 million. Earnings were $129.89 million, an increase of 6.31%.

Financial numbers in USD